FDA NDC Directory · JSON-LD · Markdown

Naproxen Sodium

NDC 59726-174 · HUMAN OTC DRUG · CAPSULE, LIQUID FILLED

Labeler / ManufacturerP & L Development, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208363
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsNAPROXEN SODIUM (220 mg/1)
Marketing started20180401
Marketing ended20261231
Package count2

External sources

Source: openFDA. Public-domain (CC0).